The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

US biotech Abcuro has reeled in $200 million in third-round financing that should allow it to complete its pivotal trial of ...

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the ...

Abcuro Inc. has raised a $200 million Series C financing to fund late-stage development and support commercial launch ...

Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

During a recent Q&A at The NAMM Show, Peter Frampton discusses his new tour and his health status as he battles the muscle disorder IBM.

The positive predictive value (PPV) of myositis antibodies for diagnosing myositis and its related conditions differs by individual antibody type. Greater diagnostic accuracy is associated with ...

Kapilakshi Malhotra, known for her performance in the Telugu film Prema Pipasi, is facing a health challenge as she has been diagnosed with myositis. The condition, an autoimmune disease affecting ...

Actress Kapilakshi Malhotra, who rose to fame with her debut in the Telugu film Prema Pipasi, has recently been diagnosed with myositis, according to reports. It is a rare and serious autoimmune ...